,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,135112,5282362,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,248,1,1,,442767,5282362,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,330,1,1,,135112,5282362,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
3,330,1,1,,442767,5282362,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
4,608,1,6,,11537386,5282362,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
5,875,1,2,,26749483,5282362,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
6,880,2,1,,26749483,5282362,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
7,880,2,1,,26749483,5282362,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
8,881,2,2,,26749483,5282362,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
9,884,1,2,,26749483,5282362,Inconclusive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
10,885,1,2,,26749483,5282362,Inactive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
11,887,1,2,,26749483,5282362,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
12,889,1,3,,26749483,5282362,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
13,892,1,2,,26749483,5282362,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
14,893,1,2,,26749483,5282362,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
15,893,1,2,,26749483,5282362,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
16,894,2,1,,26749483,5282362,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
17,900,1,3,,26749483,5282362,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
18,902,1,2,,26749483,5282362,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
19,910,1,2,,26749483,5282362,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
20,923,1,2,,26749483,5282362,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
21,924,1,2,,26749483,5282362,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
22,927,1,3,,26749483,5282362,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
23,930,1,2,,26749483,5282362,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
24,940,1,2,,26613019,5282362,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
25,995,1,2,,26749483,5282362,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
26,1030,2,1,,26749483,5282362,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
27,1033,2,2,,11537386,5282362,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
28,1204,1,2,,48421964,5282362,Active,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
29,1379,1,2,,26749483,5282362,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
30,1422,1,1,,26613019,5282362,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
31,1452,1,1,,26749483,5282362,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
32,1454,1,1,,26749483,5282362,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
33,1457,1,1,,26749483,5282362,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
34,1458,1,1,,26749483,5282362,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
35,1460,1,3,,26749483,5282362,Inconclusive,92096784.0,4137.0,6.3096,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
36,1463,1,1,,26749483,5282362,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
37,1467,1,3,,26749483,5282362,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
38,1468,1,1,,26749483,5282362,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
39,1469,1,1,,26749483,5282362,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
40,1471,2,1,,26749483,5282362,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
41,1476,2,1,,26749483,5282362,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
42,1477,1,1,,26749483,5282362,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
43,1478,2,1,,26749483,5282362,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
44,1479,1,2,,26749483,5282362,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
45,1490,2,1,,26749483,5282362,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
46,1519,1,3,,26749483,5282362,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
47,1549,1,2,,11537386,5282362,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
48,1552,1,3,,11537386,5282362,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
49,1637,1,2,,11537386,5282362,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
50,1648,1,2,,11537386,5282362,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
51,1766,1,1,,26749483,5282362,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
52,1766,1,1,,26749483,5282362,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
53,1768,1,1,,26749483,5282362,Inactive,18860839.0,4221.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
54,1768,1,1,,26749483,5282362,Inactive,56550039.0,4297.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
55,1865,1,1,,26749483,5282362,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
56,1948,1,1,,26749483,5282362,Inactive,,,15.8489,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
57,2101,1,1,,26749483,5282362,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
58,2107,1,1,,26749483,5282362,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
59,2112,1,1,,26749483,5282362,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
60,2147,1,1,,26749483,5282362,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
61,2240,1,1,,85789145,5282362,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
62,2241,1,1,,85789145,5282362,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
63,2275,1,1,,85789145,5282362,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
64,2313,1,1,,85789145,5282362,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
65,2322,1,1,,85789145,5282362,Active,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
66,2330,1,1,,85789145,5282362,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
67,2451,1,2,,26749483,5282362,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
68,2472,1,2,,26749483,5282362,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
69,2517,2,1,,26749483,5282362,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
70,2528,1,2,,26749483,5282362,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
71,2546,1,1,,26749483,5282362,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
72,2549,1,1,,26749483,5282362,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
73,2551,1,1,,26749483,5282362,Active,188536040.0,19885.0,11.2202,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
74,6820,11,1,,103166212,5282362,Unspecified,,,230.0,IC50,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,Confirmatory,8254620.0,
75,34047,9,1,,103166212,5282362,Active,,,7.0,IC50,Inhibition of hamster liver aldehyde dehydrogenase ALDH-2,Confirmatory,11563931.0,
76,88789,6,2,,103166212,5282362,Active,,,14.7,IC50,Concentration required to inhibit 50% growth of Human CEM T-lymphocytes cells,Confirmatory,9544201.0,
77,89021,6,2,,103166212,5282362,Active,,,6.13,IC50,Inhibition of the production of Interleukin-1-beta from human peripheral blood monocytes stimulated with lipopolysaccharide (LPS),Confirmatory,8496911.0,
78,89118,6,2,,103166212,5282362,Active,,,13.1,IC50,Concentration required to inhibit 50% growth of human Molt 4/C8 T-lymphocyte cells,Confirmatory,9544201.0,
79,90472,6,2,,103166212,5282362,Active,,,28.0,IC50,Inhibitory activity against phytohemagglutininin A-induced proliferation of human lymphocytes,Confirmatory,9822551.0,
80,99076,6,2,,103166212,5282362,Active,,,23.5,IC50,Concentration required to inhibit 50% growth of L1210 leukemia cells,Confirmatory,9544201.0,
81,100427,6,2,,103166212,5282362,Active,,,16.0,IC50,Tested in vitro for anti-leishmanial activity against Leishmania donovani,Confirmatory,9822551.0,
82,125224,9,1,,103166212,5282362,Active,,,4.5,IC50,Inhibition of hamster liver mitochondrial monoamine oxidase MAO,Confirmatory,11563931.0,
83,144377,7,1,,103166212,5282362,Active,1172801.0,12972.0,,,Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.,Other,9857096.0,
84,150684,6,2,,103166212,5282362,Active,,,3.12,IC50,Inhibition of proliferation of murine P388 cells,Confirmatory,9544201.0,
85,152006,6,2,,103166212,5282362,Active,,,29.6,IC50,Inhibition of [3H]hypoxanthine incorporation in Plasmodium falciparum K1,Confirmatory,11728189.0,
86,157870,6,2,,103166212,5282362,Active,,,29.6,IC50,Growth inhibition of chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake,Confirmatory,12161120.0,
87,161175,3,7,,103166212,5282362,Unspecified,,,,,Inhibition of Prostaglandin G/H synthase activity in sheep seminal vesicle was determined 100 uM,Other,8254620.0,
88,183256,3,4,,103166212,5282362,Unspecified,,,,,Inhibition of lipid peroxidation in rat liver microsomes at 1 uM,Other,8254620.0,
89,255211,8,1,,103166212,5282362,Unspecified,113832.0,24208.0,57.544,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),Confirmatory,16134935.0,
90,313629,6,2,,103166212,5282362,Unspecified,,,50.0,IC50,Blockade of human K+ channel in HEK293 cells assessed as inhibition of outward delayed rectifying K+ current,Confirmatory,18032041.0,
91,434959,1,1,,85789145,5282362,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
92,485281,1,1,,26749483,5282362,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
93,485290,1,1,,26749483,5282362,Inactive,20150581.0,,56.2341,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
94,504327,1,1,,26749483,5282362,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
95,504332,1,1,,26749483,5282362,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
96,504847,1,1,,26749483,5282362,Active,63054845.0,7421.0,44.6684,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
97,504865,1,1,,26749483,5282362,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
98,588579,1,1,,26749483,5282362,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
99,602332,1,1,,26749483,5282362,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
100,624156,1,1,,85789145,5282362,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
101,686978,1,1,,26749483,5282362,Inconclusive,79154014.0,55775.0,20.5962,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
102,686979,1,1,,26749483,5282362,Inconclusive,79154014.0,55775.0,29.0929,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
103,720532,1,1,,26749483,5282362,Inconclusive,420597.0,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
104,720533,1,1,,26749483,5282362,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
105,720579,2,1,,26749483,5282362,Inconclusive,222762.0,3707576.0,12.5893,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
106,720580,1,1,,26749483,5282362,Inconclusive,222762.0,3707576.0,12.5893,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
107,771809,1,3,,103166212,5282362,Unspecified,,,230.0,IC50,Inhibition of cyclooxygenase in rat RBL1 cells,Confirmatory,,
108,771810,1,6,,103166212,5282362,Unspecified,729945.0,25290.0,230.0,IC50,Inhibition of 5-lipoxygenase in rat RBL1 cells,Confirmatory,,
109,977599,1,1,,103166212,5282362,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
110,977602,1,2,,103166212,5282362,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
111,1095451,1,2,,103166212,5282362,Unspecified,,,,,Toxicity against third instar larve of Culex quinquefasciatus after 24 hr,Other,,
112,1115058,1,4,,103166212,5282362,Unspecified,135666.0,2152.0,,,Ratio of curcumin IC50 to compound IC50 for tissue factor in LPS-induced Homo sapiens (human) THP1 cells,Other,,
113,1115059,2,3,,103166212,5282362,Active,135666.0,2152.0,0.00011999999999999999,IC50,Inhibition of tissue factor in Homo sapiens (human) THP1-cells using factor 10a chromogenic substrate assessed as inhibition of LPS-iduced procoagulant activity incubated for 1 hr prior to LPS-challenge measured after 5 hr by spectrophotometric analysis,Confirmatory,,
114,1139721,1,1,,103166212,5282362,Unspecified,,,,,Retardation factor of the compound using chloroform/methanol at 4:1 ratio,Other,24703232.0,
115,1159524,1,1,,26749483,5282362,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
116,1159550,3,1,,252403101,5282362,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
117,1159580,2,1,,268735537,5282362,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
118,1159607,2,1,,312995865,5282362,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
119,1166454,1,2,,103166212,5282362,Unspecified,113037.0,43.0,500.0,IC50,Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,Confirmatory,25260958.0,
120,1166455,1,2,,103166212,5282362,Unspecified,116353.0,590.0,500.0,IC50,Inhibition of BuChE (unknown origin) using butyrylthiocholine iodide as substrate incubated for 25 mins by Ellman's method,Confirmatory,25260958.0,
121,1245395,1,1,,103166212,5282362,Active,113980.0,4129.0,0.182,IC50,Inhibition of recombinant human MAOB using benzylamine as substrate after 30 mins by Amplex red based spectrophotometric analysis,Confirmatory,26337020.0,
122,1245396,1,1,,103166212,5282362,Unspecified,113978.0,4128.0,100.0,IC50,Inhibition of recombinant human MAOA using p-tyramine as substrate after 30 mins by Amplex red based spectrophotometric analysis,Confirmatory,26337020.0,
123,1245397,1,1,,103166212,5282362,Unspecified,,,,,"Selectivity index, ratio of IC50 for recombinant human MAOA to IC50 for recombinant human MAOB",Other,26337020.0,
124,1259310,1,1,,333494986,5282362,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
125,1259389,1,1,,124636263,5282362,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
126,1259407,1,1,,363900179,5282362,Inactive,,,,,CCRIS mutagenicity studies,Other,,
127,1259416,1,2,,375178374,5282362,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
128,1259421,1,1,,375178374,5282362,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
